Janus Kinase Inhibition in the Aicardi-Goutières Syndrome

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2020-09, Vol.383 (10), p.986-989
Hauptverfasser:	Vanderver, Adeline, Adang, Laura, Gavazzi, Francesco, McDonald, Katherine, Helman, Guy, Frank, David B, Jaffe, Nicole, Yum, Sabrina W, Collins, Abigail, Keller, Stephanie R, Lebon, Pierre, Meritet, Jean-François, Rhee, Jullie, Takanohashi, Asako, Armangue, Thais, Ulrick, Nicole, Sherbini, Omar, Koh, Jamie, Peer, Kyle, Besnier, Constance, Scher, Carly, Boyle, Katherine, Dubbs, Holly, Kramer-Golinkoff, Julia, Pizzino, Amy, Woidill, Sarah, Shults, Justine
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Age of Onset Autoimmune Diseases of the Nervous System - drug therapy Azetidines - adverse effects Azetidines - therapeutic use Biomarkers Child Child Development - drug effects Child, Preschool Dose-Response Relationship, Drug Female Gene Expression - drug effects Humans Infant Interferons - genetics Interferons - metabolism Janus Kinase Inhibitors - adverse effects Janus Kinase Inhibitors - therapeutic use Least-Squares Analysis Male Nervous System Malformations - drug therapy Sulfonamides - adverse effects Sulfonamides - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!